Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Infliximab

Brand: Remicade┬«, Inflectra┬«, Remisima┬«
NICE TA: 
Indication: Prevention of recurrence of ulcerative colitis following surgery
Disease category: Gastro-intestinal system
Commissioning responsibility: CCG
PbR excluded: Yes

Background

There is a lack of evidence for TNF-alpha inhibitors or other biologic agents to support their use in the prevention of recurrence following surgery for UC.

Recommendation

LMMG recommendation: Black
Click here to find the definitions for the colour classifications

Reason for decision:  Not recommended for prescribing on the NHS in Lancashire

Supporting documents:

Gastroenterology Biologics Pathway (Version 1.1) (355.6 KiB)

Biosimilars of Infliximab (Version 1.1) (271.7 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black